Nanomedicine: Nanotechnology, Biology and Medicine Accepted for Coverage in MEDLINE

 Inclusion in prominent database will help locate articles published in Nanomedicine

Philadelphia, February 20, 2007 – Elsevier, the world's leading scientific, technical and medical publisher has announced that its journal, Nanomedicine: Nanotechnology, Biology and Medicine has been selected for inclusion in MEDLINE®. Maintained by the U.S. National Library of Medicine®, MEDLINE (Medical Literature Analysis and Retrieval System Online) is the premier bibliographic database containing approximately 13 million references to journal articles in life sciences with a concentration on biomedicine.

Nanomedicine: NBM Editor-in-Chief, Chiming Wei, MD, PhD, Department of Surgery, Johns Hopkins University School of Medicine, commented, "The entire Editorial Board and I are extremely pleased that Nanomedicine: NBM is being added to the MEDLINE journal collection so soon after its launch in March 2005 in recognition of its scientific merit and contribution to the field. Inclusion in this prominent database will help investigators throughout the world more easily locate articles published in Nanomedicine: NBM."

Nanomedicine: Nanotechnology, Biology and Medicine , the Official Journal of the American Academy of Nanomedicine (AANM), is an international, peer-reviewed journal published quarterly. Nanomedicine: NBM publishes basic, clinical and engineering research in the innovative field of nanomedicine. Article categories include diagnostic, experimental, clinical, engineering, pharmacological and basic nanomedicine. Nanomedicine: NBM provides the latest information in this rapidly developing field, covering both research advancements and clinical applications. The Journal publishes original clinical and investigative studies, state-of-the-art papers, reports on new equipment and techniques, review articles and more.

Nanomedicine, an offshoot of nanotechnology, refers to highly specific medical intervention at the molecular scale for curing disease or repairing damaged tissues, such as bone, muscle or nerve. A nanometer is one-billionth of a meter, too small to be seen with a conventional lab microscope. It is at this size scale – about 100 nanometers or less – that biological molecules and structures inside living cells operate.

The National Library of Medicine MEDLINE selection process is managed by an advisory committee, the Literature Selection Technical Review Committee, composed of authorities knowledgeable in the field of biomedicine, such as physicians, researchers, educators, editors, health science librarians and historians, to review and recommend the journal titles NLM should index. With inclusion in MEDLINE, citations, abstracts and indexing terms for articles published in Nanomedicine: NBM will be available online in the U.S. and throughout the world back to Volume 1/Issue 1. MEDLINE is searchable for free using PubMed at

Elsevier, a world-leading medical and scientific publisher, brings the full support of its global organization to the journal. It is recognized for its numerous long-standing and successful society-publishing partnerships, as well as excellence in all aspects of the publishing process. ScienceDirect, Elsevier’s world-class electronic platform with over 16 million users, provides online access to the full text of Nanomedicine: NBM to institutional subscribers. Members of the affiliated society and individual subscribers are able to access the journal via

# # #

About the American Academy of Nanomedicine
The American Academy of Nanomedicine is a forum to exchange ideas, communicate new findings and encourage collaboration among the diverse disciplines represented in Nanomedicine. Membership in AANM includes a subscription to Nanomedicine: Nanotechnology, Biology, and Medicine.

About Elsevier
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Research Intelligence and ClinicalKey— and publishes over 2,500 journals, including The Lancet and Cell, and more than 35,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group, a world-leading provider of information and analytics for professional and business customers across industries.

Media Contacts:
Jami E. Walker
Associate Publisher, Nanomedicine
+1 (314) 579-3342

William Deutsch
Marketing, Nanomedicine
+1 (215) 239-3651